Lipid lowering drugs.
- 10 March 1990
- Vol. 300 (6725), 667-672
- https://doi.org/10.1136/bmj.300.6725.667
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patientsAtherosclerosis, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- BezafibrateDrugs, 1987
- Effects of probucol on xanthomata regression in familial hypercholesterolemiaThe American Journal of Cardiology, 1986
- Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect.BMJ, 1985
- Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.Circulation, 1984
- Ciprofibrate in the therapy of type II hypercholesterolemia A double-blind trialAtherosclerosis, 1982
- Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug RegimenNew England Journal of Medicine, 1981
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980